Literature DB >> 19036091

No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage.

Issa J Dahabreh1, Amy V Jones, Michael Voulgarelis, Stavroula Giannouli, Christine Zoi, Christina Alafakis-Tzannatos, Marighoula Varla-Leftherioti, Haralampos M Moutsopoulos, Dimitris Loukopoulos, Stelios Fotiou, Nicholas C P Cross, Katerina Zoi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19036091     DOI： 10.1111/j.1365-2141.2008.07510.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Authors:  Elisa Rumi; Irene Bertozzi; Ilaria C Casetti; Elisa Roncoroni; Chiara Cavalloni; Marta Bellini; Emanuela Sant'Antonio; Manuel Gotti; Virginia V Ferretti; Chiara Milanesi; Edoardo Peroni; Daniela Pietra; Cesare Astori; Maria Luigia Randi; Mario Cazzola
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

2.  Contribution of JAK2 and STAT3 variants to the genetic susceptibility of recurrent miscarriage among Bahraini and Tunisian Arabs.

Authors:  Safia Messoudi; Manar A Al-Sulaiti; Amna S Al-Busaidi; Maryam Dendana; Brahim Nsiri; Wassim Y Almawi; Touhami Mahjoub
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 3.  JAK2 mutation and thrombosis in the myeloproliferative neoplasms.

Authors:  Alessandro M Vannucchi
Journal:  Curr Hematol Malig Rep       Date:  2010-01       Impact factor: 3.952

4.  Genetics of recurrent miscarriage: challenges, current knowledge, future directions.

Authors:  Kristiina Rull; Liina Nagirnaja; Maris Laan
Journal:  Front Genet       Date:  2012-03-19       Impact factor: 4.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.